The rounds this investor is named on, who it invests beside, and where it shows up.
Named on 3 rounds in the feed, most often in Biotech.
Investment firmLondon, UKcancerresearchhorizons.comRounds from 2024-12-03 to 2026-11-05
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Alethio Therapeutics A biopharmaceutical company developing therapies for myeloproliferative neoplasms (MPNs) | Series A Verified against 4 of 33 sources | $90M | 2026-11-05 | [ PART ] |
52North A University of Cambridge medtech spinout | Funding round Verified against 4 of 5 sources |
| $4.2M |
| 2026-09-29 |
| [ PART ] |
52North A University of Cambridge medtech spinout | Growth Developing, 4 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $6.0M | 2024-12-03 | [ PART ] |